11:41 AM EST - Helix BioPharma Corp. : said its second-quarter net loss narrowed to $3.67 million from $4.25 million in the prior year period. Loss per share for the quarter was $0.06, narrower than $0.08 in the year-ago period. Revenue for the quarter rose to $1.12 million from $860,000 in the comparable period. Helix BioPharma Corp.
shares T.HBP are trading down $0.14 at $2.75.
